Evidence map›Paper›PMID 34014839›Full record

ArticleThe Journal of clinical investigation2021

Multiple-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage.

Grier P Page, Tamir Kanias, Yuelong J Guo, Marion C Lanteri, Xu Zhang, Alan E Mast, Ritchard G Cable, Bryan R Spencer, Joseph E Kiss, Fang Fang and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed, 1 pooled it
9.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 1 synthesis or guideline pooled it, 91 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. HypomorphicHemaSphere · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 8 institutions in 2 countries.

Grier P PageDivision of Biostatistics and Epidemiology, RTI International, Atlanta, Georgia, USA.
Tamir KaniasVitalant Research Institute, Denver, Colorado, USA.
Yuelong J GuoDivision of Biostatistics and Epidemiology, RTI International, Durham, North Carolina, USA.
Marion C LanteriVitalant Research Institute and the Department of Laboratory Medicine, UCSF, San Francisco, California, USA.
Xu ZhangDepartment of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Alan E MastBlood Research Institute, Blood Center of Wisconsin, and Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Ritchard G CableAmerican Red Cross, Farmington, Connecticut, USA.
Bryan R SpencerAmerican Red Cross, Dedham, Massachusetts, USA.
Joseph E KissVitalant Northeast Division, Pittsburgh, Pennsylvania, USA.
Fang FangDivision of Biostatistics and Epidemiology, RTI International, Durham, North Carolina, USA.
Stacy M Endres-DigheDivision of Biostatistics and Epidemiology, RTI International, Rockville, Maryland, USA.
Donald BrambillaDivision of Biostatistics and Epidemiology, RTI International, Rockville, Maryland, USA.
Mehdi NouraieDivision of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh, Pennsylvania, USA.
Victor R GordeukDepartment of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA.
Steve KleinmanUniversity of British Columbia, Victoria, British Columbia, Canada.
Michael P BuschVitalant Research Institute and the Department of Laboratory Medicine, UCSF, San Francisco, California, USA.
Mark T GladwinPittsburgh Heart, Lung, and Blood Vascular Medicine Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
National Heart, Lung, and Blood Institute (NHLBI) Recipient Epidemiology Donor Evaluation Study–III (REDS-III) program
RTI International · USAmerican Red Cross · USPacific Research Institute · USUniversity of Illinois Chicago · USUniversity of Pittsburgh · USVitalant · USUniversity of British Columbia · CAVersiti Blood Center of Wisconsin · US

Funding

REDS-IV-P - CENTER FOR TRANSFUSION LABORATORY STUDIES (CTLS) - SARS-CoV-2/COVID-19 STUDIES75N92019D00033 · NHLBI · VITALANT · PI NORRIS, PHILIP J. · 2019 to 2024
$15.6M
NHLBI NIH HHS 75N92019D00033NHLBI NIH HHS HHSN268201100001INHLBI NIH HHS HHSN268201100002INHLBI NIH HHS HHSN268201100003INHLBI NIH HHS HHSN268201100004INHLBI NIH HHS HHSN268201100005INHLBI NIH HHS HHSN268201100007INHLBI NIH HHS HHSN268201100008INHLBI NIH HHS HHSN268201100009IWHI NIH HHS HHSN268201100001C
6 · The paper itself

Abstract

BackgroundThe evolutionary pressure of endemic malaria and other erythrocytic pathogens has shaped variation in genes encoding erythrocyte structural and functional proteins, influencing responses to hemolytic stress during transfusion and disease.MethodsWe sought to identify such genetic variants in blood donors by conducting a genome-wide association study (GWAS) of 12,353 volunteer donors, including 1,406 African Americans, 1,306 Asians, and 945 Hispanics, whose stored erythrocytes were characterized by quantitative assays of in vitro osmotic, oxidative, and cold-storage hemolysis.ResultsGWAS revealed 27 significant loci (P < 5 × 10-8), many in candidate genes known to modulate erythrocyte structure, metabolism, and ion channels, including SPTA1, ALDH2, ANK1, HK1, MAPKAPK5, AQP1, PIEZO1, and SLC4A1/band 3. GWAS of oxidative hemolysis identified variants in genes encoding antioxidant enzymes, including GLRX, GPX4, G6PD, and SEC14L4 (Golgi-transport protein). Genome-wide significant loci were also tested for association with the severity of steady-state (baseline) in vivo hemolytic anemia in patients with sickle cell disease, with confirmation of identified SNPs in HBA2, G6PD, PIEZO1, AQP1, and SEC14L4.ConclusionsMany of the identified variants, such as those in G6PD, have previously been shown to impair erythrocyte recovery after transfusion, associate with anemia, or cause rare Mendelian human hemolytic diseases. Candidate SNPs in these genes, especially in polygenic combinations, may affect RBC recovery after transfusion and modulate disease severity in hemolytic diseases, such as sickle cell disease and malaria.

Indexed as

Polymorphism, Single NucleotideAdultAsianBlack or African AmericanBlood DonorsBlood PreservationCohort StudiesCold TemperatureErythrocytesErythrocyte TransfusionEvolution, MolecularFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHemolysisHispanic or LatinoGeneticsGenetic variation

Identifiers

PMID34014839
PMCPMC8245173
OpenAlexW3161754417

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.